The Effect of a Mobile Application Based on the Social Cognitive Learning Theory on Medication Adherence and Hypertension Self-Efficacy in Patients With Hypertension: A Randomized Controlled Trial
1 other identifier
interventional
86
1 country
1
Brief Summary
In this study, a mobile application designed based on the Social Cognitive Theory was evaluated in middle-aged individuals with hypertension: H1(a): A mobile application based on the Social Cognitive Theory affects medication adherence self-efficacy levels in patients with hypertension. H0(a): A mobile application based on the Social Cognitive Theory does not affect medication adherence self-efficacy levels in patients with hypertension. H1(b): A mobile application based on the Social Cognitive Theory affects hypertension self-efficacy levels in patients with hypertension. H0(b): A mobile application based on the Social Cognitive Theory does not affect hypertension self-efficacy levels in patients with hypertension. H1(c): A mobile application based on the Social Cognitive Theory affects systolic and diastolic blood pressure levels in patients with hypertension. H0(c): A mobile application based on the Social Cognitive Theory does not affect systolic and diastolic blood pressure levels in patients with hypertension. Participants were asked to download and use the hypertension monitoring application designed by the researcher on their phones for a period of three months. A pre-test was administered through face-to-face interviews before installing the application. After using the application for three months, a post-test was conducted using the same scales through face-to-face interviews. For the control group, the same pre-test was administered through face-to-face interviews without using the application. After three months, a post-test was again conducted via face-to-face interviews. The researchers compared the data of the participants with those of the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Dec 2024
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
January 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedFirst Posted
Study publicly available on registry
July 3, 2025
CompletedJuly 3, 2025
June 1, 2025
3 months
January 29, 2025
June 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Medication Adherence Self-Efficacy Level in Hypertension Patients
A mobile app can influence medication adherence self-efficacy levels in hypertension patients.
From participation until the end-point is 3 months.
Hypertension Self-Efficacy Level in Hypertension Patients
A mobile app influences hypertension self-efficacy levels in hypertension patients.
From participation until the end-point is 3 months.
Secondary Outcomes (1)
systolic and diastolic blood pressure
From participation until the end-point is 3 months.
Study Arms (2)
Participitants
EXPERIMENTALMobile application users
Control
NO INTERVENTIONnon-users of application
Interventions
Measuring the Benefits of a 3-Month Mobile Application Use in Hypertension Patients
Eligibility Criteria
You may qualify if:
- Diagnosed with hypertension (for at least 6 months).
- Currently using antihypertensive medication.
- Voluntarily agrees to participate in the research.
- Aged between 40-64 years (Turkish Society of Hypertension and Renal Diseases, 2012; TURKSTAT, 2022).
- Literate.
- No mental or communication-impairing issues.
- Not pregnant or a breastfeeding mother.
- Able to use a smartphone with an Android operating system.
- No additional comorbid diseases (e.g., cancer, diabetes mellitus).
- Has a semi-automatic upper-arm blood pressure monitor at home.
You may not qualify if:
- Experiencing issues with internet access or mobile application usage.
- Voluntarily withdraws from the study during the research process.
- Uses an different operating system than Android operating system.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gozde Aygunlead
Study Sites (1)
Aydın Adnan Menderes University
Aydin, Efeler, 09010, Turkey (Türkiye)
Related Publications (25)
Choi JY, Choi H, Seomun G, Kim EJ. Mobile-Application-Based Interventions for Patients With Hypertension and Ischemic Heart Disease: A Systematic Review. J Nurs Res. 2020 Oct;28(5):e117. doi: 10.1097/JNR.0000000000000382.
PMID: 32501962BACKGROUNDWHO guideline Recommendations on Digital Interventions for Health System Strengthening. Geneva: World Health Organization; 2019. Available from http://www.ncbi.nlm.nih.gov/books/NBK541902/
PMID: 31162915BACKGROUNDZhang Q, Huang F, Zhang L, Li S, Zhang J. The effect of high blood pressure-health literacy, self-management behavior, self-efficacy and social support on the health-related quality of life of Kazakh hypertension patients in a low-income rural area of China: a structural equation model. BMC Public Health. 2021 Jun 10;21(1):1114. doi: 10.1186/s12889-021-11129-5.
PMID: 34112122BACKGROUNDYang S, He C, Zhang X, Sun K, Wu S, Sun X, Li Y. Determinants of antihypertensive adherence among patients in Beijing: Application of the health belief model. Patient Educ Couns. 2016 Nov;99(11):1894-1900. doi: 10.1016/j.pec.2016.06.014. Epub 2016 Jun 18.
PMID: 27378081BACKGROUNDYang Y, Liu W, Ji X, Ma C, Wang X, Li K, Li J. Extended afternoon naps are associated with hypertension in women but not in men. Heart Lung. 2020 Jan-Feb;49(1):2-9. doi: 10.1016/j.hrtlng.2019.09.002. Epub 2019 Sep 11.
PMID: 31521340BACKGROUNDArici M, Birdane A, Guler K, Yildiz BO, Altun B, Erturk S, Aydogdu S, Ozbakkaloglu M, Ersoz HO, Suleymanlar G, Tukek T, Tokgozoglu L, Erdem Y; Turk Kardiyoloji Derneg i (TKD); Turk Ic Hastaliklari Uzmanlik Dernegi (TIHUD); Turkiye Endokrinoloji ve Metabolizma Dernegi (TEMD); Turk Nefroloji Dernegi (TND); Turk Hipertansiyon ve Bobrek Hastaliklari Dernegi. [Turkish Hypertension Consensus Report]. Turk Kardiyol Dern Ars. 2015 Jun;43(4):402-9. doi: 10.5543/tkda.2015.16243. Turkish.
PMID: 26142798BACKGROUNDTezcan C, (2016). Sağlığa Yenilikçi Bir Bakış Açısı: Mobil Sağlık. Yayın No: TÜSİAD-T/2016-03/575
BACKGROUNDSümen A. (2019). Sosyal Bilişsel Teoriye Temellendirilmiş ' Çocuğumu Güneşten Koruyorum' Programının Ebeveyn Davranışlarına Etkisi, Doktora Tezi, Akdeniz Üniversitesi Sağlık Bilimleri Enstitüsü, Antalya.
BACKGROUNDShen Y, Chang C, Zhang J, Jiang Y, Ni B, Wang Y. Prevalence and risk factors associated with hypertension and prehypertension in a working population at high altitude in China: a cross-sectional study. Environ Health Prev Med. 2017 Apr 4;22(1):19. doi: 10.1186/s12199-017-0634-7.
PMID: 29165123BACKGROUNDSaleh S, Farah A, Dimassi H, El Arnaout N, Constantin J, Osman M, El Morr C, Alameddine M. Using Mobile Health to Enhance Outcomes of Noncommunicable Diseases Care in Rural Settings and Refugee Camps: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018 Jul 13;6(7):e137. doi: 10.2196/mhealth.8146.
PMID: 30006326BACKGROUNDÖzpulat F. (2015). Motivasyonel Görüşmenin Hipertansif Bireylerin Özyeterlilik Algısına ve İlaç Tedavisi Uyumuna Etkisi, Hacettepe Üniversitesi Sağlık Bilimleri Enstitüsü, Doktora Tezi, Ankara.
BACKGROUNDMatar D, Frangieh AH, Abouassi S, Bteich F, Saleh A, Salame E, Kassab R, Azar RR. Prevalence, awareness, treatment, and control of hypertension in Lebanon. J Clin Hypertens (Greenwich). 2015 May;17(5):381-8. doi: 10.1111/jch.12485. Epub 2015 Jan 24.
PMID: 25619545BACKGROUNDLu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J, Su M, Zhao H, Spatz ES, Spertus JA, Masoudi FA, Krumholz HM, Jiang L. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017 Dec 9;390(10112):2549-2558. doi: 10.1016/S0140-6736(17)32478-9. Epub 2017 Nov 5.
PMID: 29102084BACKGROUNDKurt (2020). Hipertansiyon Tanısı Alan Hastalara Verilen Öz Yönetim Desteğinin Bilgi Düzeyi, Tedaviye Uyum Ve Öz Bakım Yönetimine Etkisi. Doktora Tezi. Trakya Üniversitesi Sağlık Bilimleri Enstitüsü, Edirne.
BACKGROUNDKumar N, Khunger M, Gupta A, Garg N. A content analysis of smartphone-based applications for hypertension management. J Am Soc Hypertens. 2015 Feb;9(2):130-6. doi: 10.1016/j.jash.2014.12.001. Epub 2014 Dec 11.
PMID: 25660364BACKGROUNDKaynak, G. K. Kronik hastalıklarda öz yeterlilik algısı: Türkiye'de gerçekleştirilen çalışmalar üzerine bir derleme. Oltu Beşeri ve Sosyal Bilimler Fakültesi Dergisi, 3(2), 79-86.
BACKGROUNDKaradağ, E., Karatay, G., Akkuş, Y.(2012) Bir Aile Sağlığı Merkezine Başvuran Hipertansiyon Hastalarının İlaç Tedavisine Uyum Öz Etkililik Düzeyleri. Ege Üniversitesi Hemşirelik Fakültesi Dergisi, 28(3), 85-96.
BACKGROUNDHyder AA, Wosu AC, Gibson DG, Labrique AB, Ali J, Pariyo GW. Noncommunicable Disease Risk Factors and Mobile Phones: A Proposed Research Agenda. J Med Internet Res. 2017 May 5;19(5):e133. doi: 10.2196/jmir.7246.
PMID: 28476722BACKGROUNDHacıhasanoglu, R., Gözüm, S., ve Çapık, C. (2012). Hipertansif Hastalarda İlaca Uyum Öz-etkililik Ölçegi kısa formunun Türkçe'sinin geçerliligi. Anadulu Kardiyoloji Dergisi, 12(3), 241-248.
BACKGROUNDGönel, P. (2019). Hastaların Hipertansiyon Bilgilerinin Tedaviye Uyum ve Öz-Etkililik Düzeylerine Etkisinin Belirlenmesi (Master's thesis, Eastern Mediterranean University (EMU)-Doğu Akdeniz Üniversitesi (DAÜ)
BACKGROUNDDikmen Y. Denar Y. Başan H. Filiz N.Y, Hemşirelik Öğrencilerinin Öz Etkinlik-Yeterlilik Düzeylerinin İncelenmesi. Çağdaş Tıp Dergisi 2016,6(3),206-2013
BACKGROUNDDelibaş, L., Erci, B.(2021). Sosyal Bilişsel Kuram Temelli Eğitimle Tip 1 Diyabetli Çocukların Hastalık Yönetiminin Desteklenmesi. Turkish Journal of Family Medicine and Primary Care, 15(2), 404-413.
BACKGROUNDBuis L, Hirzel L, Dawood RM, Dawood KL, Nichols LP, Artinian NT, Schwiebert L, Yarandi HN, Roberson DN, Plegue MA, Mango LC, Levy PD. Text Messaging to Improve Hypertension Medication Adherence in African Americans From Primary Care and Emergency Department Settings: Results From Two Randomized Feasibility Studies. JMIR Mhealth Uhealth. 2017 Feb 1;5(2):e9. doi: 10.2196/mhealth.6630.
PMID: 28148474BACKGROUNDBandura A. Self Efficacy Mechanizm in Human Agency, American Agency. American Psychologist. 1982; 37(2): 122-147.
BACKGROUNDBahar B, Sosyal Öğrenme Kuramı Ve Sosyal Değişim Kuramı Perspektifinden Etik Liderlik. Balkan Sosyal Bilimler Dergisi 2019,8(16),237-242
BACKGROUND
Related Links
- WHO (2022) Guideline for the pharmacological treatment of hypertension in adults
- TÜİK HanrHalkı Bilişim Teknolojileri Kullanma Oranı
- WHO Noncommunicable Diseases Fact Sheet
- TKD Hipertansiyon Prevelansı
- Hipertansiyon Tanı ve Tedavi Klavuzu (2019)
- ''Güncel Kılavuzlar Işığında Hipertansiyon Tanı ve Tedavisi'' (2014)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Adile TÜMER, Assosciate Professor
Muğla Sıtkı Koçman University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
January 29, 2025
First Posted
July 3, 2025
Study Start
December 1, 2024
Primary Completion
March 1, 2025
Study Completion
May 1, 2025
Last Updated
July 3, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share